Federal award (BPA CALL, fiscal year 2024)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-06-18 to 2025-09-30
Current total value of award: $42481.77
Description: DRUG STANDARDS TO BE USED FOR SCREENING AND ATION OF SUSPECTED DRUG USE IN SERVICE MEMBER AND/OR POST-MORTEM URINE, BLOOD AND TISSUE SAMPLES.